Diagnosis and treatment of hepatitis B. What contributions can prisons make?
- PMID: 35411915
- PMCID: PMC8802821
- DOI: 10.18176/resp.00041
Diagnosis and treatment of hepatitis B. What contributions can prisons make?
Abstract
Hepatitis B is a parenterally and sexually transmitted infection. Vaccination for the disease is highly effective, and its inclusion in Spain as part of a systematic and universal schedule for newborns has led to a significant decrease of incidence in the national population. However, the number of inmates born in other countries some from endemic areas of HBV infection -, the mechanisms of transmission and lack of vaccination in third world countries mean that its prevalence in the prison population is higher than in the general population. These institutions therefore play an essential role in detecting and managing hepatitis B. In this paper, the situation of hepatitis B in prisons is reviewed and recommendations are proposed to optimize its control.
La hepatitis B es una infeccion de transmision parenteral y sexual. La vacunacion es altamente efectiva, y en Espana, esta incluida en el programa vacunal sistematico y universal en los recien nacidos, lo que ha comportado una importante disminucion de la incidencia en la poblacion autoctona. Sin embargo, el numero de ingresados en prision nacidos en otros paises (algunos procedentes de areas endemicas de la infeccion por el virus de la hepatitis B [VHB]), el mecanismo de transmision y la falta de vacunacion en los paises del tercer mundo, hace que su prevalencia en la poblacion penitenciaria sea mas alta que en la poblacion general. Estas instituciones tienen, por consiguiente, un papel fundamental en la deteccion y manejo de la hepatitis B. En este trabajo, se revisa la situacion de la hepatitis B en las prisiones y se proponen recomendaciones para optimizar su control.
Figures
Similar articles
-
Screening for hepatitis B virus and accelerated vaccination schedule in prison: A pilot multicenter study.Vaccine. 2019 Mar 7;37(11):1412-1417. doi: 10.1016/j.vaccine.2019.01.049. Epub 2019 Feb 4. Vaccine. 2019. PMID: 30733091
-
Ways to promote screening for hepatitis B virus and accelerated vaccination schedule in prison: Training, information, peer education.Rev Epidemiol Sante Publique. 2022 Feb;70(1):25-30. doi: 10.1016/j.respe.2022.01.001. Epub 2022 Feb 11. Rev Epidemiol Sante Publique. 2022. PMID: 35164982
-
Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.BMC Infect Dis. 2008 Mar 7;8:33. doi: 10.1186/1471-2334-8-33. BMC Infect Dis. 2008. PMID: 18328097 Free PMC article.
-
The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.Int J Infect Dis. 2008 Jan;12(1):3-11. doi: 10.1016/j.ijid.2007.04.012. Epub 2007 Jul 20. Int J Infect Dis. 2008. PMID: 17643334 Review.
-
[Immunization against viral hepatitis: an obligatory recommendation in consults for sexually transmitted diseases].Actas Dermosifiliogr. 2007 Mar;98(2):88-90. Actas Dermosifiliogr. 2007. PMID: 17397593 Review. Spanish.
References
-
- 2. Salleras L, Domínguez A, Brugera M, Plans P, Costa J, Cardeñosa N, et al. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Vaccine. 2007;25(52):8726-31. - PubMed
- Salleras L, Domínguez A, Brugera M, Plans P, Costa J, Cardeñosa N, et al. Declining prevalence of hepatitis B virus infection in Catalonia (Spain) 12 years after the introduction of universal vaccination. Vaccine. 2007;25(52):8726–8731. - PubMed
-
- 3. Llaneras J, Riveiro-Barciela M, Rando-Segura A, Marcos-Fosch C, Roade L, Velázquez F, et al. Etiologies and Features of Acute Viral Hepatitis in Spain. Clin Gastroenterol Hepatol. 2021;19(5):1030-7. - PubMed
- Llaneras J, Riveiro-Barciela M, Rando-Segura A, Marcos-Fosch C, Roade L, Velázquez F, et al. Etiologies and Features of Acute Viral Hepatitis in Spain. Clin Gastroenterol Hepatol. 2021;19(5):1030–1037. - PubMed
-
- 4. Centro Nacional de Epidemiología, Instituto de Salud Carlos III. Vigilancia epidemiológica de la Hepatitis B en España, 2019. [Internet]. Madrid: CNE-ISCIII; 2020. [Citado 24 May 2021]. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/...
- Centro Nacional de Epidemiología, Instituto de Salud Carlos III . Vigilancia epidemiológica de la Hepatitis B en España, 2019. Madrid: CNE-ISCIII; 2020. [24 May 2021]. Internet. Disponible en: https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/... .
-
- 5. Miquel M, Pardo A, Forné M, Martínez-Alpin G, Rodríguez-Castellano A, Casas M, et al. Current trends in access to treatment for hepatitis B in immigrants vs non-immigrants. Gastroenterol Rep. 2020;8(5):362-6. - PMC - PubMed
- Miquel M, Pardo A, Forné M, Martínez-Alpin G, Rodríguez-Castellano A, Casas M, et al. Current trends in access to treatment for hepatitis B in immigrants vs non-immigrants. Gastroenterol Rep. 2020;8(5):362–366. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical